These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?]. Checler F; Buée L Ann Pharm Fr; 2009 Mar; 67(2):136-53. PubMed ID: 19298897 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Alzheimer's disease: current and future therapeutic approaches. Cummings JL Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259 [TBL] [Abstract][Full Text] [Related]
11. The development of new therapeutics for Alzheimer's disease. Carter MD; Simms GA; Weaver DF Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic options in Alzheimer's disease. Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412 [TBL] [Abstract][Full Text] [Related]
13. [Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target]. Ohyagi Y Fukuoka Igaku Zasshi; 2006 Sep; 97(9):261-8. PubMed ID: 17134029 [No Abstract] [Full Text] [Related]
14. Hopes remain for an Alzheimer's vaccine. Schenk D Nature; 2004 Sep; 431(7007):398. PubMed ID: 15385984 [No Abstract] [Full Text] [Related]
20. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease. Li C; Ebrahimi A; Schluesener H Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]